Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004404 · ClinicalTrials.gov registry record · NA
Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes
A NA study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00004404: Completed NA study, sponsored by Boston Children's Hospital.
NCT00004404 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004404, a NA study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
OBJECTIVES: Determine the effectiveness of the combined use of clotrimazole and hydroxyurea on a specific panel of red cell characteristics in patients with sickle cell syndromes.
Interventions
- DRUG hydroxyurea
- DRUG clotrimazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 1997-04 |
| Est. Completion | 2002-09 |
| Phase | NA |
What the finished NCT00004404 record still lists
NCT00004404 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which hydroxyurea is the first listed.
NCT00004404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004404 about?
NCT00004404 is a clinical study titled "Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes". OBJECTIVES: Determine the effectiveness of the combined use of clotrimazole and hydroxyurea on a specific panel of red cell characteristics in patients with sickle cell syndromes.
What is the current status of trial NCT00004404?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 1997-04. Estimated completion is 2002-09.
What interventions are being tested in trial NCT00004404?
The interventions under investigation include: hydroxyurea (DRUG), clotrimazole (DRUG).
Who is sponsoring clinical trial NCT00004404?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00004404's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia